GlassScriptPhysician profile
Dean Yamaguchi
NPI 1316016397
$12,724.19
in general payments reported to CMS, 2019-2025
11 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,592 · 2020: $8,431 · 2021: $70.42 · 2022: $33.17 · 2024: $898 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437 · Travel and Lodging: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.56 |
| Travel and Lodging | $1,161.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $9,843.91 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Cook Incorporated | $1,500.00 | 2019 | |
| Cook Medical LLC | $978.60 | 2025 | Zenith Alpha, Zenith Spiral-Z |
| Boston Scientific Corporation | $126.09 | 2025 | Eluvia |
| Bolton Medical INC | $119.96 | 2025 | Treo Abdominal Stent-Graft System |
| Endologix LLC | $67.58 | 2019-2021 | |
| Silk Road Medical, INC. | $26.87 | 2020-2021 | |
| Elutia, INC. | $20.64 | 2022 | |
| Angiodynamics, INC. | $14.45 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Yamaguchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.